What Has Been The Evolution of the Breast Biopsy Market in Recent Years?
The breast biopsy market has seen considerable growth due to a variety of factors.
• The market size for breast biopsy has witnessed significant growth in the recent past. The predicted escalation is from $1.42 billion in 2024 to $1.53 billion in 2025, maintaining a Compound Annual Growth Rate (CAGR) of 7.6%.
Factors responsible for this growth during the historical phase include a surge in the number of breast cancer cases, an increase in the elderly population, heightened awareness initiatives, a rise in health care spending, and a trend towards outpatient and ambulatory care settings.
What Is the Forecasted Market Size and Growth Rate for The Breast Biopsy Market Size In The Coming Years?
The breast biopsy market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the breast biopsy market size is projected to experience robust growth. The market is forecast to expand to $2.03 billion in 2029, representing a compound annual growth rate (CAGR) of 7.3%.
This predicted growth during the forecast period can be attributed to factors such as infrastructural advancements in the healthcare sector, the rise of personalized medicine, increased healthcare accessibility in emerging regions, supportive regulatory policies and reimbursements, and the emergence of telemedicine and remote diagnostics. Key trends expected during this period include the application of robotics in biopsy procedures, an increase in home-based biopsy kits, the growing significance of genomic biopsies, a focus on patient-centric care models, ensuring data security through blockchain integration, and an emphasis on post-biopsy monitoring tools.
What Factors Are Driving Growth In The Breast Biopsy Market?
The escalating occurrence of breast cancer is predicted to stimulate the expansion of the breast biopsy market in the future. A malignant tumor emerging in the breast tissue cells is defined as breast cancer, which has the potential to metastasize to different parts of the body if not addressed promptly. Factors like extended life expectancy, enhanced detection techniques, and increasing consciousness about the malady contribute to the prevalence of this cancer. Breast biopsy, a process of securing tissue samples from dubious areas in the breast to diagnose and ascertain the features of breast cancer, is pivotal in its detection. For instance, statistics from the American Cancer Society, a non-profit U.S. organization, in January 2023, noted that the count of fresh invasive breast cancer incidents in American women amplified from approximately 281,550 in 2021 to 297,790 in 2023. Consequently, the escalating occurrence of breast cancer is propelling the expansion of the breast biopsy market.
What Are The Main Segments Of The Global Breast Biopsy Market?
The breast biopsymarket covered in this report is segmented –
1) By Type: Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kits, Liquid Biopsy Instruments, Other Types
2) By Image Guided Technology: Magnetic Resonance Imaging (MRI) Guided Breast Biopsy, Ultrasound Guided Breast Biopsy, Mammography Guided Stereotactic Biopsy, Computed Tomography (CT) Guided Biopsy, Other Image Guided Breast Biopsy
3) By Procedure: Needle Breast Biopsy, Open Surgical Breast Biopsy, Liquid Breast Biopsy
4) By Application: Hospitals, Clinics, Diagnostic Centers, Other Applications
Subsegments:
1) By Biopsy Needles: Core Biopsy Needles, Fine Needle Aspiration (FNA) Needles, Vacuum-Assisted Biopsy Needles, Automatic Biopsy Needles
2) By Guidance Systems: Ultrasound Guidance Systems, MRI Guidance Systems, Stereotactic Guidance Systems, Tomosynthesis Guidance Systems
3) By Biopsy Tables: Adjustable Biopsy Tables, Specialty Biopsy Tables, Imaging-Compatible Biopsy Tables
4) By Localization Wires: Hookwire Localization Devices, Radioguided Localization Wires, Magnetic Seed Localization Systems
5) By Assay Kits: Breast Cancer Assay Kits, Biomarker Detection Kits, Genetic Testing Kits for Breast Cancer
6) By Liquid Biopsy Instruments: Circulating Tumor Cell (CTC) Isolation Devices, Plasma DNA Isolation Kits, Liquid Biopsy Analysis Systems
7) By Other Types: Biopsy Adhesives, Specimen Collection and Transport Devices, Patient Management Systems
Pre-Book The Breast Biopsy Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Breast Biopsy Market?
Leading organizations in the breast biopsy market are prioritizing the development of innovative solutions such as vacuum-assisted breast biopsy systems, in order to deliver improved care to patients with benign lesions. This type of system is a medical instrument that uses a suction process to extract multiple tissue samples from a potentially problematic breast area via a singular needle insertion. For example, in August 2022, US-based medical device firm, Devicor Medical Products, Inc., introduced the Mammotome Revolve EX Dual Vacuum-Assisted Breast Biopsy System. This new product features a dual vacuum mechanism for superior tissue gathering, providing increased sample volume and enhanced accuracy. The system's ergonomic design comprises a revolving probe for exceptional maneuverability and a single insertion process to reduce patient discomfort. Additionally, this system incorporates real-time imaging integration for meticulous targeting and efficient conducting of biopsy procedures.
Who Are the Key Players In The Breast Biopsy Market?
Major companies operating in the breast biopsy market are:
• Medtronic PLC
• Siemens Healthineers AG
• Fujifilm Holdings Corporation
• Becton Dickinson and Company (BD)
• Koninklijke Philips
• GE HealthCare Technologies Inc.
• Hologic Inc.
• The Cooper Companies Inc.
• Merit Medical Systems
• Argon Medical Devices
• Canon Medical Systems Corporation
• Devicor Medical Products Inc.
• Mermaid Medical Group
• Planmed Oy
• Menarini-Silicon Biosystems
• Seno Medical Instruments Inc.
• Surgical Innovations Group
• Sterylab Srl
• Dilon Technologies Inc.
• INRAD Inc.
• Promaxo Inc.
What Is The Most Dominant Region In The Breast Biopsy Market?
North America was the largest region in the breast biopsy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breast biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
